Skip to content

13F-HR filed by NEA Management Company, LLC

NEA Management Company, LLC filed this 13F-HR for the quarter ended 2014-09-30, filed 2014-10-24, with 35 holding rows worth $1,967,502,000.

Accession
0001512848-14-000006
Filed
2014-10-24
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2014

A holdings report, 35 entries on the cover page, a total value of $1,967,502,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,967,502,000 with VALUE read as thousands by filing date, 13F file number 028-14302. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
GROUPON INC399473107COMMON STOCK54,351,573$363,069,000thousands by filing date
TESARO INC881569107COM9,854,255$265,277,000thousands by filing date
OPOWER INC68375Y109COM8,997,290$169,689,000thousands by filing date
EPIZYME INC29428V104COM5,149,740$139,609,000thousands by filing date
CVENT INC23247G109COM4,994,106$126,700,000thousands by filing date
CLOVIS ONCOLOGY INC189464100COM2,279,781$103,411,000thousands by filing date
ARDELYX INC039697107COM6,621,199$94,087,000thousands by filing date
SUPERNUS PHARMACEUTICALS868459108COM10,650,000$92,549,000thousands by filing date
HYPERION THERAPEUTICS INC44915N101COM2,384,221$60,130,000thousands by filing date
GLYCOMIMETICS INC38000Q102COM8,575,135$59,511,000thousands by filing date
TRIVASCULAR TECHNOLOGIES INC89685A102COM3,945,191$57,126,000thousands by filing date
ATRIUM THERAPEUTICS INCN71546100COM6,480,171$54,628,000thousands by filing date
HIVE007786106Stock4,861,455$38,989,000thousands by filing date
AMICUS THERAPEUTICS INC03152W109COM5,653,029$33,636,000thousands by filing date
SUNESIS PHARMACEUTI-CALS INC867328502COM4,659,333$33,268,000thousands by filing date
ROKA BIOSCIENCE INC775431109COM3,220,433$32,365,000thousands by filing date
BOINGO WIRELESS INC09739C102COM4,467,960$31,857,000thousands by filing date
CARE COM INC141633107COM3,260,989$26,577,000thousands by filing date
TREVENA INC89532E109COM3,811,691$24,471,000thousands by filing date
NEKTAR THERAPEUTICS640268108COM1,825,600$22,035,000thousands by filing date
VITAE PHARMACEUTICALS INC92847N103COM2,613,199$19,939,000thousands by filing date
LEXICON PHARMACEUTICALS INC528872104COM11,676,000$16,463,000thousands by filing date
OREXIGEN THERAPEUTICS INC686164104COMMON STOCK3,709,000$15,800,000thousands by filing date
MILLENNIAL MEDIA INC60040N105COM8,224,752$15,298,000thousands by filing date
ZHONE TECHNOLOGIES INC NEW98950P884COM4,781,290$12,909,000thousands by filing date
Alimera Sciences Inc16259103 CS2,255,639$12,226,000thousands by filing dateThe CUSIP as filed is malformed.
TARGACEPT INC87611R306COM4,566,666$11,554,000thousands by filing date
CHANNELADVISOR CORP159179100COM556,692$9,130,000thousands by filing date
AURINIA PHARMACEUTICALS INC COM05156V102Stock2,546,843$8,150,000thousands by filing date
RIGEL PHARMACEUTICALS INC766559603COMMON STOCK3,243,150$6,292,000thousands by filing date
TRANSCEPT PHARMACEUTICALS IN89354M106COM2,086,755$4,236,000thousands by filing date
EXELIXIS INC COM30161Q104Stock2,207,000$3,377,000thousands by filing date
ARQULE INC04269E107COM2,520,316$2,823,000thousands by filing date
AGILE THERAPEUTICS INC00847L100COM29,850$218,000thousands by filing date
NEUROMETRIX INC641255104COM57,273$103,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001512848-14-000006this filing2014-10-24acceptance time not in the bulk data set